Induced pluripotent stem cells (iPSCs) derived from patients with early-onset ovarian cancer carrying BRCA1 gene mutations possess the capability to differentiate into fallopian tube epithelial (FTE)-like structures (19). This evidence concerns the gene BRCA1 and ovarian carcinoma.